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THE PROBLEM OF THE ACTUAL DIAGNOSTICS
One major unmet diagnostic need is to have a FAST, RELIABLE AND 
SENSITIVE POINT OF CARE DEVICE
The provision of a result (test) at the point in time at which the 
result will be used to make a decision and take appropriate 
action which will result in an improved health outcome




• In any place at any time
• Personalized care







Patients are connected to the health system by sensor networks
POC diagnostics Central monitoring system & service 
home workplace









Caliper Life Sciences, 
Hitachi, Philips                           
Fluidigm Technology…
Lab-on-a-chip devices can potentially perform diagnostic procedures on human 
blood, enabling cheap, fast, disposable tests to be performed at the POC.







Few of them can be used outside laboratory
Trained personal
BUT….. 
The majority of “Lab-on-a-Chip” are simple planar microfluidic devices 
fabricated by photolithography on substrates as glass, silicon or polymers
90% OF THE DETECTION METHODS 












• In any place at any time
• Personalized care





• Sources and detectors
Micro/Nanotechnolgy based-biosensors
 Total Analysis System: integration of 
sources, sensors, detectors, flow 
system, electronics and data processing 
on a compact device.
 Silicon and polymer Technology: Mass 
Production. Low-cost fabrication.
 Sensor packed arrays 
SMARKET ANALYSIS
Food safety
Clinical DiagnosticsEnvironmental control 
Homeland security
• Genomics and proteomics
• Chemical synthesis
• Metabolite analysis













Market for POC devices 




1º.- 8712 M€ in IVD (Growth rate 6%)
2º.- 1520 M€ in microarrays (Growth rate 20%) 
Immunodiagnostic in vitro in Europe in 2005
Source: Freedonia-group market Research
897 M€ in Spain
POTENTIAL IMPACT
POC DEVICES: unique opportunity in the diagnostic market
By offering a novel and competitive technology a 
































Global market $40 billones (2010)







In-situ and real-time data 
Imaging to the cellular level
High precision surgery tools using sensors





Complete analysis in minutes 





Portable devices with battery 
High resolution displays 
Benefits
Self diagnostics 
Automatic transmission of data to the 





Person in charge: Dr. L. Lechuga/ Dr. K. 
Zinoviev 
Person in charge: Dr. M. Álvarez 
Person in charge: Dr. L.G. 




















MAIN STEP: Surface biofunctionalization
Applies to a wide range of binding biointeractions 
Bacteria recognition
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E. Coli E. Coli
On-going projects
Platform based on Surface Plasmon Resonance sensor
Early detection of cancer biomarkers 
Toxic pesticides (water control) and residues in urine
Clinical analysis of hormones in 
human fluids (serum, urine)
Label-free, real-time, high sensitivity
DNA and RNA Detection
RNA Listeria innocua

























Triplex is 21% more efficient than duplex







Single-point mutations in 
DNA sequences




















Identification of alternative 
splicing isoforms
5 6 76
FAS gene exons 5-6-7 
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Anal. Bioanal. Chem. 387, 2757 (2007)
Talanta 78, 1011 (2009). 
Clin. Chim. Acta 403, 56 (2009)
Anal. Chim. Acta 647, 202 (2009)
SPR BIOSENSOR FOR POC DIAGNOSTICS
Clinical diagnosis of Gonadotropic Hormones  (IMMUNOASSAYS) 
in human samples (urine, serum) WITHOUT PRETREATMENT
hGH (human Growth hormone)
hTSH (human thyroid stimulating hormone)
hFSH (follicle stimulating hormone )
hLH (luteinizing hormone) 
Sensia SPR as clinical analysis tool 
for the determination of  fertile 
period,  the  start of the menopause 
and the diagnostic of  endocrine and 
reproductive  disorders
Detection of DNA single-base mutations at Gene BRCA-1












































SPR BIOSENSOR FOR POC DIAGNOSTICS











 25 mer Complementary
























Sequence with a mismatch
Anal Bioanal Chem. 2009. 393(4):1173-82
PCCP 2010, 12: 3301-3308






























































































185delAG 916delTT R1443X 5382insC
19
Platform based on Nanoplasmonics sensors
Shape & Size & Embedded Medium 
are variables to tune the LSPR position  
Nanoholesl Nanodiscsi Nanodimersi r Nanoparticlesrti l
Dark-field
For low density 
of NPs
Open the possibility of highly dense nanosensing arrays 
for thousands of analytes
Platform based on photonic Micro/nanosensors 
Interferometers




Silicon and polymer 
technology













Platform based on silicon microcantilevers






























2560 cantilevers per wafer
20 cantilevers per chip










































































• Need of high amounts of sample: (time 
consuming, expensive)
• Non-specific interactions
• Indirect read-out: fluorescent labeling. Labels 
restric assay types
• Low sensitivity for single mismatch detection
• Inconsistent activity of immobilised proteins
Future opportunities
Bride DNAGroom  DNA
• Drastic reduction of sample amount
• Direct read-out: real time analysis
• High sensitivity
• Micro/nanotechnology: mass 
production with low cost
“Lab-on-a-chip” Nanobiosensors 
as an advanced platform Array of microcantilevers
CIBER-BBN Equipment Platform
Biodeposition Unit
Surface Plasmon Resonance (SENSIA)
Biodetection Unit
The platform is offered as a 
self-service, however a specific 
training by the scientific and 
technical members of the 
nanoB2A group will be 
provided. 



























Y  Y  Y  Y  Y









































Plasmonics: SPR, Magneto-SPR and LSPR (nanostructures)
Integrated optics: Nanophotonic biosensor (MZI)
Nanomechanical biosensors (standard and optical) 
Biofuncionalization with biological receptors
Microfluidics integration
Lab-on-a-chip platforms (in-vitro and in-vivo)
Applications: clinical diagnostics, environmental control
SU8 microchannel
Silicon Nitride (wg 
core layer)
Silicon Oxide (wg 
cladding layer)
MORE INFO IN 
www.cin2.es/biosensores
